Kasia Shields, PharmD, MBA, BCOP, BCPS
Chicago—In the face of escalating cancer treatment costs, several organizations have developed tools or payment models to help promote value in cancer care, which place a greater emphasis on quality of care. They are likely to cause shifts in both practice and drug development, according to speakers at the 2016 annual HOPA Oncology Pharmacy Practice Management Program.
The American Society of Clinical Oncology (ASCO) has proposed payment reform